Page 25 - 2021_06-Haematologica-web
P. 25
The post-HCT microbiome: effects and targeted therapy
refractory intestinal acute graft-vs.-host dis- ease with fecal microbiota transplantation: a pilot study. Front Immunol. 2018;9:2195.
122.Kaito S, Toya T, Yoshifuji K, et al. Fecal microbiota transplantation with frozen cap- sules for a patient with refractory acute gut graft-versus-host disease. Blood Adv. 2018;2(22):3097-3101.
123. van Lier YF, Davids M, Haverkate NJE, et al. Donor fecal microbiota transplantation ame- liorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med. 2020;12(556): eaaz8926.
124.DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-Resistant E. coli bacteremia transmit- ted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043-2050.
125. Bilinski J, Lis K, Tomaszewska A, et al. Eosinophilic gastroenteritis and graft-versus- host disease induced by transmission of Norovirus with fecal microbiota transplant. Transpl Infect Dis. 2021;23(1):e13386.
126.Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical prac- tice. Gut. 2017;66(4):569-580.
Cell. 2018;174(6):1388-1405.e21.
129.Ott SJ, Waetzig GH, Rehman A, et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology. 2017;152(4):
799-811.
130.Han L, Zhang H, Chen S, et al. Intestinal
microbiota can predict acute graft-versus- host disease following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019;25(10): 1944-1955.
131.Kusakabe S, Fukushima K, Maeda T, et al. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol. 2020;188 (3):438-449.
127.
Golob JL, DeMeules MM, Loeffelholz T, et al. Butyrogenic bacteria after acute graft-ver- sus-host disease (GVHD) are associated with the development of steroid-refractory GVHD. Blood Adv. 2019;3(19):2866-2869.
128.Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features.
haematologica | 2021; 106(8)
2053